FDA Is Expanding Transparency Efforts To Focus On Industry Questions
This article was originally published in The Pink Sheet Daily
Sharfstein said the agency has split up its transparency efforts into three groups, adding one dedicated to explaining its inner workings to regulated industry.
You may also be interested in...
Agency's transparency initiative may include a tracking system similar to Health Canada's so that reviewers can avoid having to field phone calls from sponsors asking about the status of an application.